Efficacy of Chinese herbal medicine compared with a macrolide in the treatment of chronic rhinosinusitis without nasal polyps

American Journal of Rhinology and Allergy

Volumn 26, Issue 4, 2012, Pages 293-297

  Jiang, Rong San ^a,b   Wu, Shang Heng ^a   Tsai, Chen Chen ^a   Li, Ya Hsin ^b   Liang, Kai Li ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ERYTHROMYCIN; SACCHARIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHINESE MEDICINE; CHRONIC RHINOSINUSITIS; DRUG EFFICACY; FEMALE; HERBAL MEDICINE; HUMAN; INTESTINE TRANSIT TIME; MAJOR CLINICAL STUDY; MALE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CHRONIC DISEASE; DRUGS, CHINESE HERBAL; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 84864151382     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3778     Document Type: Article

References (35)

1. Macdonald KI, McNally JD, and Massoud E. Quality of life and impact of surgery on patients with chronic rhinosinusitis. J Otolaryngol Head Neck Surg 38:286-293, 2009.
2. Alobid I, Bernal-Sprekelsen M, and Mullol J. Chronic rhinosinusitis and nasal polyps: The role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy 63:1267-1279, 2008.
3. Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am J Med 117:20S-25S, 2004.
4. Wood AJ, and Douglas RG. Pathogenesis and treatment of chronic rhinosinusitis. Postgrad Med J 86:359-364, 2010.
5. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114:1369-1375, 2004. (Pubitemid 39575892)
6. Statham MM, and Seiden A. Potential new avenues of treatment for chronic rhinosinusitis: An anti-inflammatory approach. Otolaryngol Clin North Am 38:1351-1365, 2005. (Pubitemid 41737843)
7. Suzuki H, Ikeda K, Honma R, et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62:121-127, 2000. (Pubitemid 30248562)
8. Wallwork B, Coman W, Feron F, et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 112:1827-1830, 2002.
9. Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189-193, 2006. (Pubitemid 44383921)
10. Tamaoki J, Kadota J, and Takizawa H. Clincial implications of the immunomodulatory effects of macrolides. Am J Med 117:5S-11S, 2004.
11. Park HH, Park IH, Cho JS, et al. The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy 24:348-353, 2010.
12. Newton JR, Santangeli L, Shakeel M, and Ram Bl. Use of complementary and alternative medicine by patients attending a rhinology outpatient clinic. Am J Rhinol Allergy 23:59-63, 2009.
13. Guo R, Canter PH, and Ernst E. Herbal medicines for the treatment of rhinosinusitis: A systematic review. Otolaryngol Head Neck Surg 135:496-506, 2006. (Pubitemid 44441648)
14. Chiang LC, Chang JS, Chen CC, et al. Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med 31:355-362, 2003.
15. Han EH, Park JH, Kim JY, and Jeong HG. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells. Food Chem Toxicol 47:1659-1666, 2009.
16. Lau KM, Lee KM, Koon CM, et al. Immunomodulatory and anti- SARS activities of Houttuynia cordata. J Ethnopharmacol 118:79-85, 2008.
17. Lee JS, Kim IS, Kim JH, et al. Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response. J Ethnopharmacol 117:34-40, 2008.
18. Li C, Zhao Y, Liang C, and An H. Observations of the curative effect with various liquids for postoperative irrigation of ESS of treating chronic sinusitis and nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15:53-54, 2001.
19. Lin TY, Liu YC, Jheng JR, et al. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med 37:143-158, 2009.
20. Lu HM, Liang YZ, Yi LZ, and Wu XJ. Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol 104:245-249, 2006. (Pubitemid 43234111)
21. Park E, Kum S, Wang C, et al. Anti-inflammatory activity of herbal medicines: Inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am J Chin Med 33:415-424, 2005. (Pubitemid 40909139)
22. Feng ZH. The efficacy of Tsang-Erh-San in treatment of pediatric chronic sinusitis. Liaoning J Trad Chin Med 33:1451, 2006.
23. Wei MH, Liang LU, Lu YT, et al. The therapeutic effects of compound xanthium solution on chronic sinusitis following endoscopic surgery. Clin J Otolaryngol Intergrat Trad West Med 12:198-200, 2004.
24. Liang KL, Su YC, Tsai CC, et al. Postoperative care with Chinese herbal medicine or amoxicillin after functional endoscopic sinus surgery: A randomized, double-blind, placebo-controlled study. Am J Rhinol Allergy 25:170-175, 2011.
25. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129(suppl):S1-S32, 2003.
26. Liang KL, Twu CW, Shiao JY, et al. Validation of the Taiwanese version of the 20-Item Sino-nasal Outcome Test. J Taiwan Otolaryngol Head Neck Surg 46:6-13, 2011.
27. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 117:S35-40, 1997. (Pubitemid 27435427)
28. Mukerji SS, Pynnonen MA, Kim HM, et al. Probiotics as adjunctive treatment for chronic rhinosinusitis: A randomized controlled trial. Otolaryngol Head Neck Surg 140:202-208, 2009.
29. Thomas M, Yawn B, Price D, et al. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007-A summary. Prim Care Respir J 17:79-89, 2008. (Pubitemid 351847085)
30. Cervin A, and Wallwork B. Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis. Otolaryngol Clin N Am 38:1339-1350, 2005. (Pubitemid 41737842)
31. Soler ZM, and Smith TL. What is the role of long-term macrolide therapy in the treatment of recalcitrant chronic rhinosinusitis? Laryngoscope 119:2083-2084, 2009.
32. Wang JD. Establishment of an active surveillance system for Chinese herbal medicines. Yearb Chin Med Pharm 24:157-280, 2006.
33. Lord GGM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 354:481-482, 1999. (Pubitemid 29368929)
34. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 22:195-206, 2002. (Pubitemid 34496472)
35. Wang L, Cui X, Cheng L, et al. Adverse events to Houttuynia injection: A systematic review. J Evid Based Med 3:168-176, 2010.